Schoefbaenker, M.; Neddermeyer, R.; Guenther, T.; Mueller, M.M.; Romberg, M.-L.; Classen, N.; Hennies, M.T.; Hrincius, E.R.; Ludwig, S.; Kuehn, J.E.;
et al. Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort. Vaccines 2023, 11, 1832.
https://doi.org/10.3390/vaccines11121832
AMA Style
Schoefbaenker M, Neddermeyer R, Guenther T, Mueller MM, Romberg M-L, Classen N, Hennies MT, Hrincius ER, Ludwig S, Kuehn JE,
et al. Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort. Vaccines. 2023; 11(12):1832.
https://doi.org/10.3390/vaccines11121832
Chicago/Turabian Style
Schoefbaenker, Michael, Rieke Neddermeyer, Theresa Guenther, Marlin M. Mueller, Marie-Luise Romberg, Nica Classen, Marc T. Hennies, Eike R. Hrincius, Stephan Ludwig, Joachim E. Kuehn,
and et al. 2023. "Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort" Vaccines 11, no. 12: 1832.
https://doi.org/10.3390/vaccines11121832
APA Style
Schoefbaenker, M., Neddermeyer, R., Guenther, T., Mueller, M. M., Romberg, M.-L., Classen, N., Hennies, M. T., Hrincius, E. R., Ludwig, S., Kuehn, J. E., & Lorentzen, E. U.
(2023). Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort. Vaccines, 11(12), 1832.
https://doi.org/10.3390/vaccines11121832